Analysis of multiple steroids in saliva in the EPAD study
A new paper entitled “The European Prevention of Alzheimer’s Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer’s disease dementia” has been published in the journal Frontiers Neurology.
In this article, authors define and discuss the substantial assets of the EPAD project for the scientific community, patient population, and industry, describe the EPAD structure with a focus on how the public and private sector interacted and collaborated within the project, reflect how IMI specifically supported the achievements of the above, and conclude with a view for future
If you are interested to know more about the EPAD project, which recruited over 2,000 research participants into the EPAD longitudinal cohort study (LCS) and included over 400 researchers from 39 partners, you can read the article here: https://doi.org/10.3389/fneur.2022.1051543
Congratulations to all authors, Stina Saunders, Sarah Gregory, Matthew H. S. Clement, Cindy Birck, Serge van der Geyten and Craig W. Ritchie, on behalf of the EPAD Consortium!
Related posts
